Clinical Trial

Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma

Name: Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma — clinical trial record (NCT06798363)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2/3

View on ClinicalTrials.gov →

Summary

The main objective of this study was to determine the efficacy of different doses of propranolol in the treatment of ulcerattion infantile hemangioma (IH).

Protocol Amendment History 1 change

notable Enrollment reduced: 40 -> 24 participants 2026-07-22

Trial Details

NCT Number	NCT06798363
Lead Sponsor	West China Hospital
Conditions	Infantile Hemangioma
Enrollment	24 participants
Start Date	2025-05-02
Primary Completion	2026-06-30 (estimated)
Study Completion	2026-08-01 (estimated)
Updated on ClinicalTrials.gov	2026-07-21